Stockscreener 앱 받기
1.33
4.32%
-0.06
시간 외 거래:
1.32
-0.01
-0.75%
전일 마감가:
$1.39
열려 있는:
$1.4
하루 거래량:
20,074
Relative Volume:
0.02
시가총액:
$16.36M
수익:
$31.56M
순이익/손실:
$-46.89M
주가수익비율:
-0.4385
EPS:
-3.0329
순현금흐름:
$-26.70M
1주 성능:
-15.82%
1개월 성능:
-28.11%
6개월 성능:
-31.79%
1년 성능:
-78.32%
1일 변동 폭
$1.30
$1.40
1주일 범위
$1.30
$1.7002
52주 변동 폭
$1.0909
$6.30
Casi Pharmaceuticals Inc Stock (CASI) Company Profile
CASI을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CASI
Casi Pharmaceuticals Inc
|
1.33 | 21.53M | 31.56M | -46.89M | -26.70M | -3.0329 |
|
VRTX
Vertex Pharmaceuticals Inc
|
421.67 | 109.22B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
628.00 | 67.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
423.47 | 57.35B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
831.48 | 50.87B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
182.77 | 39.72B | 447.02M | -1.18B | -868.57M | -6.1812 |
Casi Pharmaceuticals Inc Stock (CASI) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2021-05-18 | 개시 | BTIG Research | Buy |
| 2021-04-26 | 개시 | Mizuho | Buy |
| 2020-10-23 | 개시 | Oppenheimer | Outperform |
| 2016-09-22 | 개시 | Maxim Group | Buy |
| 2015-10-29 | 재개 | H.C. Wainwright | Buy |
| 2015-06-23 | 개시 | H.C. Wainwright | Buy |
모두보기
Casi Pharmaceuticals Inc 주식(CASI)의 최신 뉴스
CASI Pharmaceuticals to Participate at Guggenheim Healthcare Innovation Conference - ACCESS Newswire
CASI (NASDAQ: CASI) fireside chat Nov 12 at Guggenheim Healthcare Innovation Conf. Boston - Stock Titan
Is CASI Pharmaceuticals Inc. stock a top momentum playQuarterly Earnings Summary & Weekly Return Optimization Alerts - newser.com
Is CASI Pharmaceuticals Inc. stock gaining market sharePortfolio Update Report & Long-Term Safe Investment Plans - newser.com
How to read the order book for CASI Pharmaceuticals Inc.2025 Big Picture & Precise Entry and Exit Recommendations - newser.com
Using data models to predict CASI Pharmaceuticals Inc. stock movementJuly 2025 Snapshot & AI Forecasted Stock Moves - newser.com
CASI Pharmaceuticals Announces Upcoming Presentation of Clinical Results for CID-103 at the 67th American Society of Hematology (ASH) Annual Meeting - Corsicana Daily Sun
CASI Pharmaceuticals (NASDAQ: CASI) to present CID-103 ITP Phase 1 poster at ASH on Dec 7 - Stock Titan
What MACD and RSI say about CASI Pharmaceuticals Inc.Quarterly Earnings Summary & Free Accurate Trade Setup Notifications - newser.com
Can CASI Pharmaceuticals Inc. stock resist sector downturnsM&A Rumor & Safe Entry Point Identification - newser.com
Smart tools for monitoring CASI Pharmaceuticals Inc.’s price actionJuly 2025 Short Interest & Fast Moving Stock Watchlists - newser.com
How resilient is CASI Pharmaceuticals Inc. stock in market downturnsMarket Performance Report & Long-Term Capital Growth Ideas - newser.com
How CASI Pharmaceuticals Inc. stock performs in weak economyWeekly Earnings Recap & Expert Approved Trade Ideas - newser.com
Can CASI Pharmaceuticals Inc. stock deliver sustainable ROELayoff News & Real-Time Volume Analysis Alerts - newser.com
Will CASI Pharmaceuticals Inc. stock attract more institutional investorsJuly 2025 Reactions & Long-Term Growth Plans - newser.com
CASI Pharmaceuticals Forms Death Cross, Signaling Potential Bearish Trend - Markets Mojo
Is CASI Pharmaceuticals Inc. stock attractive for passive investorsMarket Activity Summary & Safe Entry Point Alerts - newser.com
CASI Pharmaceuticals Forms Golden Cross, Signaling Potential Bullish Breakout - Markets Mojo
Anti-CD38 Antibody Clinical, Companies, Therapeutic Assessment, Therapies, Treatment Algorithm, Pipeline Analysis | I-MAB Biopharma, Takeda, HLX15, Ancora Biotech, CASI Pharmaceuticals - Barchart.com
Casi Pharmaceuticals Inc (CASI) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.45%
0.86%
자본화:
|
볼륨(24시간):